Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming
- PMID: 23704920
- PMCID: PMC3660533
- DOI: 10.1371/journal.pone.0063577
Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming
Abstract
Transient overexpression of defined combinations of master regulator genes can effectively induce cellular reprogramming: the acquisition of an alternative predicted phenotype from a differentiated cell lineage. This can be of particular importance in cardiac regenerative medicine wherein the heart lacks the capacity to heal itself, but simultaneously contains a large pool of fibroblasts. In this study we determined the cardio-inducing capacity of ten transcription factors to actuate cellular reprogramming of mouse embryonic fibroblasts into cardiomyocyte-like cells. Overexpression of transcription factors MYOCD and SRF alone or in conjunction with Mesp1 and SMARCD3 enhanced the basal but necessary cardio-inducing effect of the previously reported GATA4, TBX5, and MEF2C. In particular, combinations of five or seven transcription factors enhanced the activation of cardiac reporter vectors, and induced an upregulation of cardiac-specific genes. Global gene expression analysis also demonstrated a significantly greater cardio-inducing effect when the transcription factors MYOCD and SRF were used. Detection of cross-striated cells was highly dependent on the cell culture conditions and was enhanced by the addition of valproic acid and JAK inhibitor. Although we detected Ca(2+) transient oscillations in the reprogrammed cells, we did not detect significant changes in resting membrane potential or spontaneously contracting cells. This study further elucidates the cardio-inducing effect of the transcriptional networks involved in cardiac cellular reprogramming, contributing to the ongoing rational design of a robust protocol required for cardiac regenerative therapies.
Conflict of interest statement
Figures






Similar articles
-
Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5.PLoS One. 2015 Jun 5;10(6):e0125384. doi: 10.1371/journal.pone.0125384. eCollection 2015. PLoS One. 2015. PMID: 26047103 Free PMC article.
-
Cardiac gene activation analysis in mammalian non-myoblasic cells by Nkx2-5, Tbx5, Gata4 and Myocd.PLoS One. 2012;7(10):e48028. doi: 10.1371/journal.pone.0048028. Epub 2012 Oct 29. PLoS One. 2012. PMID: 23144723 Free PMC article.
-
Stoichiometric optimization of Gata4, Hand2, Mef2c, and Tbx5 expression for contractile cardiomyocyte reprogramming.Sci Rep. 2019 Oct 18;9(1):14970. doi: 10.1038/s41598-019-51536-8. Sci Rep. 2019. PMID: 31628386 Free PMC article.
-
Direct Cardiac Reprogramming: A Novel Approach for Heart Regeneration.Int J Mol Sci. 2018 Sep 5;19(9):2629. doi: 10.3390/ijms19092629. Int J Mol Sci. 2018. PMID: 30189626 Free PMC article. Review.
-
Direct Cardiac Reprogramming for Cardiovascular Regeneration and Differentiation.Keio J Med. 2020 Sep 25;69(3):49-58. doi: 10.2302/kjm.2019-0008-OA. Epub 2020 Jan 9. Keio J Med. 2020. PMID: 31915320 Review.
Cited by
-
Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming.Genesis. 2016 Jul;54(7):398-406. doi: 10.1002/dvg.22947. Epub 2016 Jun 1. Genesis. 2016. PMID: 27194122 Free PMC article.
-
Suppression of canonical TGF-β signaling enables GATA4 to interact with H3K27me3 demethylase JMJD3 to promote cardiomyogenesis.J Mol Cell Cardiol. 2021 Apr;153:44-59. doi: 10.1016/j.yjmcc.2020.12.005. Epub 2020 Dec 24. J Mol Cell Cardiol. 2021. PMID: 33359755 Free PMC article.
-
Emerging Insights into Sall4's Role in Cardiac Regenerative Medicine.Cells. 2025 Jan 21;14(3):154. doi: 10.3390/cells14030154. Cells. 2025. PMID: 39936946 Free PMC article. Review.
-
In situ reprogramming to transdifferentiate fibroblasts into cardiomyocytes using adenoviral vectors: Implications for clinical myocardial regeneration.J Thorac Cardiovasc Surg. 2017 Feb;153(2):329-339.e3. doi: 10.1016/j.jtcvs.2016.09.041. Epub 2016 Sep 23. J Thorac Cardiovasc Surg. 2017. PMID: 27773576 Free PMC article.
-
Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.Circulation. 2017 Mar 7;135(10):978-995. doi: 10.1161/CIRCULATIONAHA.116.024692. Epub 2016 Nov 10. Circulation. 2017. PMID: 27834668 Free PMC article.
References
-
- Murry CE, Reinecke H, Pabon LM (2006) Regeneration gaps: observations on stem cells and cardiac repair. Journal of the American College of Cardiology 47: 1777–1785. - PubMed
-
- Maltsev VA, Rohwedel J, Hescheler J, Wobus AM (1993) Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mechanisms of development 44: 41–50. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous